- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0031911

About Synapes Life Sciences Private Limited
Data last updated:
Synapes Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2016PTC290166. Its GSTIN is 07AAWCS6725R1Z5 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ajay Kumar Sharma and Neeru Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 310 Third Floor Plot No. – 11, Mlu Pocket Aggarwal Plaza Sector – 12, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.59 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹9.99 Lakh (net margin 2.8%) and EBITDA of ₹24.35 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 21% over five years.
The company is associated with 1 brand: Synapes Life Sciences. Court records list 1 case involving the company, including 1 filed against it.
Synapes Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0031911). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synapeslifesciences.com.
Company details
Recognitions & Rankings of Synapes Life Sciences
Contact details
Synapes Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is synapeslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 310 Third Floor Plot No. – 11, Mlu Pocket Aggarwal Plaza Sector – 12, New Delhi, Delhi, India – 110078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synapes Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Synapes Life Sciences operates one associated brand: Synapes Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development and provision of pharmaceutical medicines in healthcare sectors, focusing on critical care and patient outcomes. | synapeslifesciences.com |
Business activity
The main business activity of Synapes Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Synapes Life Sciences Private Limited, buy the company report.
Financials of Synapes Life Sciences Private Limited
FY 2025 filings availableSynapes Life Sciences Private Limited reported revenue of ₹3.59 Cr (up 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 3% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synapes Life Sciences Private Limited, buy the company report.
Board of directors of Synapes Life Sciences Private Limited
Synapes Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Sharma Also directs: Skychip Silicon Private Limited | Director | 17 Apr 2017 | 9 Years 6 Months | Current |
| Neeru Sharma | Director | 17 Apr 2017 | 9 Years 6 Months | Current |
| Archna Sharma | Director | 27 Jan 2016 | 10 Years 9 Months | Current |
Auditor
Synapes Life Sciences Private Limited is audited by SINGHAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGHAL & CO | FY 2022 | 025050N |
Shareholding
The shareholding of Synapes Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Synapes Life Sciences Private Limited, buy the company report.
Legal cases
Synapes Life Sciences Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharmaceutical Industries Ltd. | Disposed |
To see the full case history of Synapes Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synapes Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synapes Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAWCS6725R1Z5 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Synapes Life Sciences Private Limited, buy the company report.
Recent activity
Synapes Life Sciences Private Limited has 7 board changes on record since 2016: 3 appointments and 4 cessations. The latest: Aaditya Sharma ceased to be Director on 31 Oct 2023.
Frequently asked questions
Synapes Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 January 2016 (10+ years old) and is registered under CIN U74900DL2016PTC290166.
Synapes Life Sciences has 3 current directors:
- Ajay Kumar Sharma - Director
- Neeru Sharma - Director
- Archna Sharma - Director
The latest financial statements of Synapes Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Synapes Life Sciences is 07AAWCS6725R1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Synapes Life Sciences is U74900DL2016PTC290166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synapes Life Sciences has 1 court case on record: 1 filed against it.
Synapes Life Sciences was incorporated on 27 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Aaditya Sharma ceased to be Director on 31 Oct 2023. Renu Sharma ceased to be Director on 24 Feb 2020. Ajay Kumar Sharma ceased to be Additional Director on 30 Sep 2017. Synapes Life Sciences has 7 board changes on record in total.
Yes, Synapes Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0031911).
Synapes Life Sciences can be reached through the website synapeslifesciences.com. Its registered office is in New Delhi, Delhi, India.

